Apogee Therapeutics, Inc.
APGE
Výsledovka
Rozvaha
Peněžní toky
Ukazatele
Klíčové metriky
V miliónech (USD)
| Operating Income | TTM | 2024 | 2023 | |
|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 68,424.00 | |
| Selling General & Admin Expenses | 0.00 | 0.00 | 24,579.00 | |
| Depreciation & Amortization | 1,082.00 | 189.00 | 9,018.00 | |
| Total Operating Expenses | 283,020.00 | 216,870.00 | 93,003.00 | |
| Operating Income | -283,420.00 | -216,870.00 | -93,003.00 | |
| Net Income | TTM | 2024 | 2023 | |
|---|---|---|---|---|
| Interest Income | 29,980.00 | 34,742.00 | 9,018.00 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | |
| Other Expense | 29,980.00 | 34,742.00 | 9,018.00 | |
| IBT | -253,440.00 | -182,128.00 | -83,985.00 | |
| Income Tax Expense | 234.00 | 18.00 | 0.00 | |
| Net Income | -253,674.00 | -182,146.00 | -83,985.00 | |
| Per Share Data | TTM | 2024 | 2023 | |
|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | |
| Shares Outstanding | 58,773.73 | 55,193.97 | 25,005,774.00 | |
| Diluted Shares Outstanding | 58,773.73 | 55,193.97 | 25,005,774.00 | |
| Current Assets | TTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Cash And Equivalents | 307,299.00 | 141,789.00 | 118,316.00 | 151,890.00 | |
| Short Term Investments | 368,929.00 | 378,864.00 | 277,143.00 | 0.00 | |
| Total Cash & ST Investments | 676,228.00 | 520,653.00 | 395,459.00 | 151,890.00 | |
| Accounts Receivable | 0.00 | 4,697.00 | 0.00 | 0.00 | |
| Inventory | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Current Assets | 5,625.00 | 4,363.00 | 2,950.00 | 57.00 | |
| Total Current Assets | 681,853.00 | 529,713.00 | 398,409.00 | 152,055.00 | |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 4,941.00 | 13,324.00 | 2,594.00 | 0.00 | |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-Term Investments | 113,689.00 | 210,416.00 | 0.00 | 0.00 | |
| Other Long-Term Assets | 174.00 | 498.00 | 401.00 | 0.00 | |
| Total Long-Term Assets | 118,804.00 | 224,238.00 | 2,995.00 | 0.00 | |
| Total Assets | 800,657.00 | 753,951.00 | 401,404.00 | 152,055.00 | |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Accounts Payable | 5,527.00 | 1,071.00 | 2,143.00 | 418.00 | |
| Short-Term Debt | 1,682.00 | 3,234.00 | 2,202.00 | 0.00 | |
| Other Current Liabilities | 17,408.00 | 24,255.00 | 16,213.00 | 9,562.00 | |
| Current Liabilities | 24,617.00 | 28,560.00 | 20,558.00 | 9,980.00 | |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Long-Term Debt | 2,401.00 | 8,597.00 | 933.00 | 0.00 | |
| Capital Leases | 2,401.00 | 11,831.00 | 2,034.00 | 0.00 | |
| Def. Tax Liability | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Liabilities | 27,018.00 | 37,157.00 | 21,491.00 | 9,980.00 | |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Common Stock | 1.00 | 1.00 | 0.00 | 0.00 | |
| Retained Earnings | -189,680.00 | -305,916.00 | -123,770.00 | -39,785.00 | |
| Comprehensive Income | -289.00 | 915.00 | 329.00 | 0.00 | |
| Total Common Equity | 773,639.00 | 716,794.00 | 379,913.00 | -39,785.00 | |
| Other | TTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Total Debt | 4,083.00 | 11,831.00 | 2,034.00 | 0.00 | |
| Book Value | 773,639.00 | 716,794.00 | 379,913.00 | 142,075.00 | |
| Cash Flow From Operating Activities | TTM | 2024 | 2023 | |
|---|---|---|---|---|
| Net Income | -118,485.00 | -182,146.00 | -83,985.00 | |
| Depreciation & Amortization | 65.00 | 189.00 | 0.00 | |
| Stock-Based Compensation | 13,600.00 | 23,332.00 | 6,103.00 | |
| Change Working Capital | 2,438.00 | -2,002.00 | 6,105.00 | |
| Change In Accounts Receivable | 0.00 | 0.00 | 0.00 | |
| Change In Accounts Payable | -5,342.00 | -1,072.00 | 1,613.00 | |
| Change In Inventories | 0.00 | 0.00 | 0.00 | |
| Other Non-cash Items | -1,558.00 | -10,547.00 | -2,984.00 | |
| Cash from Operations | -110,570.00 | 0.00 | -74,761.00 | |
| Cash Flow From Investing Activities | TTM | 2024 | 2023 | |
|---|---|---|---|---|
| Capital Expenditure | -569.00 | -1,152.00 | -167.00 | |
| Acquisitions | 0.00 | 0.00 | 0.00 | |
| Investments | -656,602.00 | -649,450.00 | -303,743.00 | |
| Sales of Investment | 182,810.00 | 350,140.00 | 30,000.00 | |
| Other Investing Activities | -51.39 | 0.00 | 0.00 | |
| Cash from Investing | -708,579.00 | 0.00 | -273,910.00 | |
| Cash Flow From Financing Activities | TTM | 2024 | 2023 | |
|---|---|---|---|---|
| Debt Repaid | 0.00 | 0.00 | 0.00 | |
| Debt Issued | 4,083.00 | 9,797.00 | 2,034.00 | |
| Issuance of Common Stock | 765,761.00 | 0.00 | 315,391.00 | |
| Repurchase of Common Stock | -0.21 | 0.00 | 0.00 | |
| Dividends Paid | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | 317,535.52 | 0.00 | 0.00 | |
| Cash from Financing | 767,455.00 | 0.00 | 315,391.00 | |
| Cash position | TTM | 2024 | 2023 | |
|---|---|---|---|---|
| Net Change in Cash | 182,230.00 | 23,473.00 | -33,280.00 | |
| Closing Cash Balance | 307,299.00 | 142,083.00 | 118,610.00 | |
| Free Cash Flow | TTM | 2024 | 2023 | |
|---|---|---|---|---|
| Free Cash Flow | -111,139.00 | -172,326.00 | -74,928.00 | |
| Real Free Cash Flow | -124,739.00 | -195,658.00 | -81,031.00 | |
| Nacenění | TTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| P/E | 0.00 | -13.73 | -16.85 | -27.04 | |
| P/EG | 0.00 | -0.14 | -0.15 | 0.00 | |
| P/B | 4.10 | 3.49 | 3.73 | -27.04 | |
| P/S | 0.00 | 0.00 | 0.00 | 0.00 | |
| P/FCF | -10.10 | -14.51 | -18.89 | -65.49 | |
| P/OFC | -10.23 | -14.61 | -18.93 | -65.49 | |
| Price/EV | -8.28 | -10.94 | -15.47 | 0.00 | |
| Marže | TTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Gross Profit Margin | 0.0% | 0.0% | 0.0% | 0.0% | |
| EBIT Margin | 0.0% | 0.0% | 0.0% | 0.0% | |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | |
| Operating Profit Margin | 0.0% | 0.0% | 0.0% | 0.0% | |
| Net Profit Margin | 0.0% | 0.0% | 0.0% | 0.0% | |
| Finanční zdraví | TTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Current Ratio | 16.36 | 18.55 | 19.38 | 15.24 | |
| Quick Ratio | 16.36 | 18.55 | 19.38 | 15.24 | |
| Solvency Ratio | 0.00 | -4.90 | -3.49 | -0.63 | |
| Cash Ratio | 3.94 | 4.96 | 5.76 | 15.22 | |
| Debt To Assets Ratio | 0.02 | 0.02 | 0.01 | 0.00 | |
| Debt To Equity Ratio | 0.02 | 0.02 | 0.01 | 0.00 | |
| Financial Leverage Ratio | 1.06 | 1.05 | 1.06 | -3.82 | |
| Debt Service Coverage Ratio | 0.00 | -67.01 | 0.00 | 0.00 | |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | -3.36 | |
| Data na akcii | TTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income Per Share | -2.08 | -3.30 | -1.66 | -0.79 | |
| Cash Per Share | 8.65 | 9.43 | 7.81 | 3.00 | |
| Shareholders Equity Per Share | 10.60 | 12.99 | 7.50 | -0.79 | |
| Free Cash Flow Per Share | -3.97 | -3.12 | -1.48 | -0.32 | |
| Dividend Per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Efektivita | TTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Effective Tax Rate | 100.0% | 0.0% | 0.0% | 0.1% | |
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | |
| Payables Turnover | 0.07 | 0.00 | 0.00 | 0.00 | |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
